Since bacterial nitroreduction may play a critical role in the activation of nitropolycyclic aromatic hydrocarbons, we have used batch and semicontinuous culture systems to determine the ability of intestinal microflora to metabolize the carcinogen 6-nitrochrysene (6-NC). 6-NC was metabolized by the intestinal microflora present in the semicontinuous culture system to 6-aminochrysene (6-AC), N-formyl-6-aminochrysene -(6-FAC), and 6-nitrosochrysene (6-NOC). These metabolites were isolated and identified by high-performance liquid chromatography, mass spectrometry, and UV-visible spectrophotometry and compared with authentic compounds. Almost all of the 6-NC was metabolized after 10 days. Nitroreduction of 6-NC to 6-AC was rapid; the 6-AC concentration reached a maximum at 48 h. The ratio of the formation of 6-AC to 6-FAC to 6-NOC at 48 h was 93.4:6.3:0.3. Interestingly, compared with results in the semicontinuous culture system, the only metabolite detected in the batch studies was 6-AC. The rate of nitroreduction differed among human, rat, and mouse intestinal microflora, with human intestinal microflora metabolizing 6-NC to the greatest extent. Since 6-AC has been shown to be carcinogenic in mice and since nitroso derivatives of other nitropolycyclic aromatic hydrocarbons are biologically active, our results suggest that the intestinal microflora has the enzymatic capacity to generate genotoxic compounds and may play an important role in the carcinogenicity of 6-NC.
Nitrated polycyclic aromatic hydrocarbons (nitro-PAHs) are potent mutagens in the Salmonella typhimurium reversion assay, genotoxic in mammalian test systems, and carcinogenic in laboratory animals (1, 4, 10, 14, 15, 27, 33, 41) . Nitro-PAHs have been identified in airborne particulate matter, diesel engine exhaust, carbon black, and certain photocopier fluids (23, 27, (34) (35) (36) (38) (39) (40) . Since these nitroPAHs are ubiquitous in the environment, they may constitute a carcinogenic risk to humans.
6-Nitrochrysene (6-NC) has been reported to be the most potent lung and liver carcinogen of the nitro-PAHs examined in the newborn mouse tumorigenesis assay (3, 41) . The nitration of chrysene causes a drastic increase in tumorigenicity, particularly in the lung, over that of the parent PAH in this bioassay (7, 41) . Nitro-PAHs require metabolic activation to reactive electrophilic species to elicit carcinogenic activity, and although the molecular basis for these carcinogenic effects is still not clear, extensive studies have suggested that a combination of pathways, including nitroreduction, nitro-PAH ring-oxidation, and 0-acetylation, may be critical in the metabolic activation of nitro-PAHs (1, 9, 15, 18) .
The intestinal microflora may have a significant role in the metabolic activation of nitro-PAHs (2, 16, 37). Monocultures of bacteria and fecal suspensions derived from rat, human, and monkey intestinal contents rapidly reduce nitro-PAHs to the corresponding amines (5, 20, 21, 25) . Reduction of the nitro group by intestinal microflora nitroreductases to arylamines implies the formation of electrophilic species such as nitroso-and N-hydroxy-intermediates which could bind to cellular nucleophiles (1) . The importance of the intestinal microflora in nitroreduction has also been demonstrated in germ-free versus conventional animal experiments (11) . Recently, we have used the semicontinuous culture system * Corresponding author.
developed by Miller and Wolin (28) which mimics the lumen of the large intestine to determine the role of the human intestinal microflora in the biotransformation of xenobiotics (6, 17, 24, 25) , including the nitro-PAH 1-nitropyrene (25) . In this study, we examined the human intestinal microfloramediated metabolism of 6-NC by using this culture system. In addition, we compared the abilities of rat, human, and mouse intestinal microflora as well as pure cultures of facultative and obligate anaerobic bacteria to metabolize 6-NC. Metabolites were identified, and the kinetics of production were determined. The potential toxicological significance of intestinal microflora metabolism of 6-NC is discussed.
MATERIALS AND METHODS
Chemicals. [3, 4, 9, 10 -3H]6-NC (1.1 mCi/mmol) was obtained from Chemsyn Science Laboratories, Lenexa, Kans. Nonradioactive 6-NC, the synthesis of which has been described previously (12, 13, 31) (24) . All other chemicals were analytical-grade reagents.
Intestinal microflora culture and biotransformation conditions. (i) Semicontinuous culture experiments. The experimental design of the semicontinuous culture system was the same as described in earlier studies (17, (24) (25) (26) (19) .
(ii) Mixed culture studies of human, rat, and mouse intestinal microflora. Human intestinal microflora were obtained from freshly voided feces from a healthy male volunteer at the NCTR. The sample was collected in a sterile polyethylene bag which was thoroughly flushed with oxygen-free nitrogen. A 5-ml sample of a 1:20 suspension of the feces in brain heart infusion broth was used as the inoculum after the removal of coarse debris by aseptic filtration.
Rat and mouse intestinal microflora were obtained from 90-to 120-day-old CD female rats and BALB/c mice from colonies maintained at the NCTR. The animals were anesthetized with ether, and the small and large intestines were removed through a midventral incision. Fecal pellets were then aseptically removed and rapidly transferred anaerobically to 50 ml of brain heart infusion broth. All of the cultures were incubated under anaerobic conditions at 37°C for 24 h.
(iii) Pure culture experiments. Many of the organisms listed in Table 1 
RESULTS
Semicontinuous culture experiments. Fermentation by the in vitro culture was similar to that reported in previous studies using the semicontinuous culture system (17, (24) (25) (26) 28) and verified the presence of an anaerobic microflora similar in activity to that believed to occur in vivo (8, 42) . The formation of short-chain fatty acids was used as a measure of the activity of the microflora. Acetate, propionate, and butyrate were the major fatty acids detected, but low levels of lactic, valeric, and caproic acids were also consistently present (data not shown and had an intense M+-28 peak at m/z 215 (Fig. 2) . The mass and UV spectra (X max, 274 nm) were identical to those of authentic 6-AC. The compound eluting at 20.5 min (Fig. 1) had an HPLC retention time identical to that of authentic 6-FAC and displayed UV (A max, 270 nm) and mass spectral (M+, mlz 271, m/z 243, m/z 215) properties similar to those of the standard. The compounds eluting at 18.0 and 37.5 min had identical HPLC retention times and UV spectral properties similar to those of authentic 6-AAC and 6-NOC, respectively. Insufficient material was available for further characterization of these minor metabolites.
The time course for the metabolism of [3H]6-NC by the human intestinal microflora is shown in Fig. 3 . Samples were taken over a period of 10 days, and the amounts of organicsolvent-extractable metabolites were determined by HPLC. Almost all of the [3H]6-NC was metabolized after 10 days. Nitroreduction to 6-AC was rapid and reached a maximum at 48 h. 6-AC, 6-FAC, and 6-NOC accounted for 93.4, 6.3, and 0.3%, respectively, of the total organic-solvent-extractable metabolites after 48 h of incubation. 6-AC and 6-NOC steadily declined over the remainder of the experimental period without reaching minima. 6-FAC displayed a similar decline but exhibited some variability between days 3 and 5. Formation of 6-AAC was detected only on days 4 and 5, at concentrations of 1.02 and 0.92 nmol per culture sample, respectively.
Mixed intestinal microflora experiments. The relationship between human, rat, and mouse intestinal microflora and metabolism of 6-NC was evaluated by incubating bacterial suspensions derived from the rat and mouse intestinal contents and human feces with [3H]6-NC for 24 h. At the timed intervals indicated in Fig. 4 , samples were removed and assayed for 6-NC metabolites by HPLC. To account for variability of sample source, each experiment was conducted four times, and the typical results are reported. In contrast to the results with the semicontinuous culture system, only 6-AC was detected as a metabolite. The rates of nitroreduction were consistently different among human, rat, and mouse intestinal microflora, with human intestinal microflora metabolizing 6-NC to 6-AC to the greatest extent in all experiments. This difference in nitroreductase activity is probably due to the variance in the predominant genera of intestinal microflora in each sample. The major organisms identified from the rat and mouse intestinal contents were species of Eubacterium, Bacteroides, and Lactobacillus, whereas the human samples contained the above organisms as well as species of Actinomyces, Bifidobacterium, and Peptococcus.
Pure culture experiments. Thirteen strains of obligate and facultative anaerobic bacteria were screened for the ability to metabolize 6-NC. All of the microorganisms metabolized 6-NC to 6-AC. The level of nitroreduction was low for all the cultures (Table 1 ) compared with levels found in previous studies in this laboratory with 1-nitropyrene and 6-nitrobenzo[a]pyrene (5, 20) . In the S. typhimurium strains, anaerobic metabolism of 6-NC was always greater than aerobic metabolism (Table 1) .
Metabolism of 6-NC 1-nitropyrene, and 6-nitrobenzo[aJpyrene by human intestinal microflora. Since 6-NC was reduced 40- to 6-AC to a lesser extent than in previous studies of other nitrated PAHs (5, 20) , it was of interest to compare amounts of nitroreduction of various nitro-PAHs under the same conditions. Human intestinal microflora were incubated under anaerobic conditions with 1-nitropyrene, 6-nitrobenzo[a]pyrene, and 6-NC and assayed for nitro-PAH disappearance and arylamine formation with time (Fig. 5) . After 2 h of incubation, the intestinal microflora reduced 94% of 1-nitropyrene, 50% of 6-nitrobenzo[a]pyrene, and 14% of 6-NC to the corresponding amine. This distinct difference in rates of nitroreduction (1-nitropyrene > 6-nitrobenzo[a]pyrene > 6NC) continued during the course of the incubation period.
DISCUSSION
There has been considerable discussion recently concerning the development of new methods to determine the risk associated with human exposure to genotoxic substances.
The human intestinal microflora plays an important role in the pharmacological and toxicological dynamics of many compounds (2, 16, 37) , and it is important to understand the roles of both host and microflora metabolism in determining toxicity. The semicontinuous culture system used in this study offers several advantages over pure and mixed culture methods for determining the metabolic capacity of the human intestinal microbial ecosystem (26) . This culture system isolates the activity of the microflora from that of the rest of the host and is especially useful in the study of the potential human health effects resulting from prolonged xenobiotic exposure, since it supports an active microbial community for extended periods. Furthermore, the data of the present study suggest that the semicontinuous culture system may be more directly applicable to in vivo human intestinal microbial xenobiotic metabolism by virtue of the greater bacterial and metabolic diversity exhibited by the system over that of less complex methods.
The pathways involved in the metabolic activation of 6-NC are of particular interest, because while this compound has low direct-acting mutagenic activity in bacteria relative to those of many other nitro-PAHs (32, 39) , it is the most potent of the nitro-PAHs tested thus far as a lung and liver carcinogen in the preweanling mouse tumorigenicity assay (3, 41) . Nitroreduction is believed to play a central role in the metabolic activation of many nitro-PAHs to mutagenic and carcinogenic species (1) , and intestinal microflora may play a major physiological role in the generation of reduced metabolites of many nitro-PAHs. Comparisons of the metabolism of 1-nitropyrene in germ-free and conventionally reared animals suggest the physiological predominance of intestinal microflora nitroreductase activity over that of the host cells (11) . Similarly, 1-nitropyrene is rapidly reduced when combined with human feces or incubated with anaerobic bacteria autochthonous to the human large intestine (20, 21, 25) . Nitroreduction of nitro-PAHs, including 6-NC, by host enzymes has been observed in vitro with postmitochondrial rat liver supernatants under conditions of reduced oxygen tension (9, 30, 38) . In the case of 6-NC, as oxygen tension is increased, amine formation decreases, with a concomitant increase in oxygenated metabolites (9) .
Most of the bacterial studies on the activation of nitroPAHs have been with S. typhimurium strains. Although this method has provided insight into the biochemical mechanisms involved in nitro-PAH-induced carcinogenesis, this approach may not truly reflect the bacterium-mediated metabolism of these compounds in experimental animals and humans, since S. typhimurium strains are not normally distributed in the gastrointestinal tract. In this study, we used a semicontinuous culture system developed by Miller and Wolin (28) to investigate the human intestinal microflora-mediated metabolism of [3H]6-NC. This microbial culture system simulates the microbial parameters of the human large intestine and allows for direct determination of the capacity of the microflora to transform xenobiotics (26) . The positive temporal relationship between 6-AC and 6-NOC formation (Fig. 3) reported here. There is no data on the biological activity of 6-NOC or N-hydroxy-6-AC, but both of these compounds would be expected to be reactive with cellular nucleophiles and could therefore be of toxicological significance. In fact, we have found that N-hydroxy-6-AC is highly reactive with DNA in vitro; the rate and extent of reaction are 2-to 10-fold greater than those reported for other carcinogenic N-hydroxy arylamines (8a) . Moreover, the reductive formation of 6-AC could also be of further toxicological significance, since this arylamine has long been recognized to induce hepatomas and pulmonary adenomas when administered to newborn mice (33) and hepatomas, pulmonary adenomas, and skin malignancies when applied topically to adult mice (22) . A direct comparison of the carcinogenic activities of 6-NC, 6-AC, 6-NOC, and N-hydroxy-6-AC would be of interest and might aid in determining the roles of the various metabolites formed by the intestinal microflora in the toxicological actions of 6-NC. In the semicontinuous culture systems, but not in the batch culture systems, further metabolism of 6-AC to N-formylated and N-acetylated derivatives was also observed. In the absence of evidence to the contrary, it is assumed that these pathways are involved in the detoxification of 6-NC (Fig. 6) .
Although nitroreduction has been shown to be an important activation pathway for nitro-PAHs, in some cases other pathways, including esterification of metabolically formed N-hydroxy derivatives and aromatic ring oxidation, have also been implicated (1, 9, 15, 18) . The relative significance of these toxification pathways often varies with different nitro-PAHs (14, 15) . For example, nitroreduction is critical for the mutagenic effects of 1-nitropyrene (18) , while aromatic ring oxidation appears to be more important in the genotoxicity of 6-nitrobenzo[a]pyrene (14) . In the case of 6-NC, the relative importance of oxidative and reductive pathways has not been resolved. In S. typhimurium TA100, 1,2-dihydro-1,2-dihydroxy-6-NC was identified as a major proximate mutagenic metabolite, but the metabolites responsible for the mutagenicity of 6-NC in strain TA98 were not determined (9) . In the preweanling mouse, the carcinogen-DNA adducts formed following the ihtraperitoneal administration of 6-NC and 6-AC are chromatographically identical and the major adduct formed is not derived from N-hydroxy-6-AC (K. B. Delclos, R. P. Walker, K. L. Dooley, P. P. Fu, and F. F. Kadlubar, Cancer Res., in press). This suggests that while nitroreduction is critical, additional metabolic 
